This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.

RSA 326-B:18 · Advanced Practice Registered Nurse; Licensure

Title: XXX: OCCUPATIONS AND PROFESSIONS
Chapter: 326-B · NURSE PRACTICE ACT
Status: current
Official source linked: Yes

Official source Copy section link

326-B:18 Advanced Practice Registered Nurse; Licensure. –

Copy link

An applicant for initial APRN licensure shall:

Copy link

(a)

Hold a current license as a registered nurse;

Copy link

(b)

Have graduated with a graduate degree earned in an accredited advanced practice registered nurse education program or have graduated before July 1, 2004 from an APRN education program accredited by a national accrediting body;

Copy link

(c)

Be currently certified by a board-recognized national certifying body in the specialty for which the applicant was educated; and

Copy link

(d)

Meet other criteria as established by the board.

Copy link

II.

[Repealed.] Source. 2005, 293:1. 2009, 54:4, 5, eff. July 21, 2009. 2024, 327:112, III, eff. July 1, 2024.

Copy link

Source note

Source. 2005, 293:1. 2009, 54:4, 5, eff. July 21, 2009. 2024, 327:112, III, eff. July 1, 2024.

Source history

2005, 293:1
2009, 54:4, 5, eff. July 21, 2009
2024, 327:112, III, eff. July 1, 2024

Related materials

Bill relationships

2026 HB1321 reference
cian licensed under this chapter, a physician associate licensed under RSA 328-D acting within the scope of their practice, or an advanced practice registered nurse licensed under RSA 326-B acting within the scope of their practice. 329:56 Administration of Elective Intravenous Therapy. Elective intravenous therapy may only be administered by a physician licensed under this chapter, a physician associ
2026 HB1796 reference · effective 2027-01-01
rgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physician associate licensed pursuant to RSA 328-D, or an advanced practice registered nurse pursuant to RSA 326-B, who is registered by the department to recommend treatment with psilocybin. XX. “Qualified therapy provider” means a physician and surgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physic
2026 HB1796-FN reference · effective 2027-01-01
rgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physician associate licensed pursuant to RSA 328-D, or an advanced practice registered nurse pursuant to RSA 326-B, who is registered by the department to recommend treatment with psilocybin. XX. “Qualified therapy provider” means a physician and surgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physic
2026 HB470 reference
(ADA). (g) The requirement that the physical presence of the dentist licensed under RSA 317-A:7, an anesthesiologist licensed under RSA 329, or a nurse anesthetist licensed under RSA 326-B:18 is required while general anesthesia, deep sedation or moderate sedation is in effect. (h) The establishment of the qualifications of dentists to administer general anesthesia or deep sedation, which may include a resi
2026 SB453 reference
d by the commissioner or his designee shall be for a period not to exceed 2 years; except in any case where a licensed physician, advanced practice registered nurse licensed under RSA 326-B, or physician associate licensed under RSA 329-D documents a lasting medical necessity, in which case the waiver shall be for a period not to exceed 4 years. The applicant may reapply for the waiver before such period e
2025 HB254 reference
tions to be used in medical aid in dying: (1) A physician licensed pursuant to RSA 329; (2) An osteopathic physician licensed pursuant to RSA 329; (3) An advanced practice registered nurse licensed pursuant to RSA 326-B; or (4) A pharmacist licensed pursuant to RSA 318; provided, however, that a pharmacist shall not qualify as an attending health care provider under RSA 137-M:1, II or as a consulting health care provider unde